Performance Technologies Inc
Symbol: PTIX (NASDAQ)
Company Description:
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
- Today's Open: $3.35
- Today's High: $3.42
- Today's Low: $3.26
- Today's Volume: 77.91K
- Yesterday Close: $3.43
- Yesterday High: $4.07
- Yesterday Low: $3.28
- Yesterday Volume: 341.95K
- Last Min Volume: 1
- Last Min High: $3.383
- Last Min Low: $3.321
- Last Min VWAP: $3.383
- Name: Performance Technologies Inc
- Website: https://www.protagenic.com
- Listed Date: 2003-10-31
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001022899
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $6.57M
- Round Lot: 100
- Outstanding Shares: 1.91M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-17 | 8-K/A | View |
2025-09-10 | 10-QT | View |
2025-08-28 | 8-K/A | View |
2025-08-25 | SCHEDULE 13G/A | View |
2025-08-22 | 8-K | View |
2025-08-14 | NT 10-Q | View |
2025-08-13 | 8-K | View |
2025-07-30 | 8-K | View |
2025-07-24 | 8-K | View |
2025-07-08 | SCHEDULE 13G | View |
2025-06-27 | 8-K | View |
2025-05-21 | 8-K | View |
2025-05-20 | 8-K | View |
2025-05-19 | DEFA14A | View |
2025-05-19 | 8-K | View |
2025-05-13 | 10-Q | View |
2025-05-05 | 8-K | View |
2025-04-29 | 8-K | View |
2025-04-18 | 8-K | View |
2025-03-31 | 10-K | View |